Richard Barker joins Aegate as a senior advisor

pharmafile | January 11, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  ABPI, Aegate, Richard Barker 

Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a senior advisor.

Aegate operates an authentication and traceability service for the pharma industry, addressing the need to protect patients from counterfeit, recalled or expired medicines.

Dr Richard Barker OBE, is the director of the Centre for Accelerating Medical Innovations and an advisor to a number of healthcare companies. He was previously director general of the ABPI and board member of EFPIA (the European Federation of Pharmaceutical Industries and Associations).

His past operating roles also include chief executive of Chiron Diagnostics, a global diagnostics company, and general manager of IBM’s Worldwide Healthcare Solutions business. He also led McKinsey’s European pharmaceuticals and healthcare practice.

Advertisement

Sir David Cooksey, chairman of Aegate, added: “Richard’s substantial pharmaceutical industry expertise will be invaluable, now that new European Legislation for falsified medicines has made it clear that patient safety systems such as Aegate’s are going to become a legal requirement.”

New legislation will require the pharmaceutical industry to uniquely barcode each box of medicine such that they can be checked by pharmacists at the time of dispensing, using authentication software, to confirm the item is not recalled or falsified. 

Related Content

pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!

brexit-hintergrund_web

UK life sciences industry does not want no-deal Brexit, says ABPI Chief

Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …

mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike …

The Gateway to Local Adoption Series

Latest content